S. Vitello

1.9k total citations · 1 hit paper
11 papers, 1.1k citations indexed

About

S. Vitello is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Surgery. According to data from OpenAlex, S. Vitello has authored 11 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Oncology, 7 papers in Pulmonary and Respiratory Medicine and 2 papers in Surgery. Recurrent topics in S. Vitello's work include Colorectal Cancer Treatments and Studies (9 papers), Cancer Treatment and Pharmacology (4 papers) and Lung Cancer Treatments and Mutations (4 papers). S. Vitello is often cited by papers focused on Colorectal Cancer Treatments and Studies (9 papers), Cancer Treatment and Pharmacology (4 papers) and Lung Cancer Treatments and Mutations (4 papers). S. Vitello collaborates with scholars based in Italy, Argentina and Japan. S. Vitello's co-authors include Gianluca Masi, Alfredo Falcone, Cristina Granetto, Enrico Cortesi, V. Picone, I. Brunetti, Giovanni Benedetti, C. Barbara, Sergio Ricci and E. Pfanner and has published in prestigious journals such as Journal of Clinical Oncology, Annals of Oncology and Lung Cancer.

In The Last Decade

S. Vitello

10 papers receiving 1.1k citations

Hit Papers

Phase III Trial of Infusional Fluorouracil, Leucovorin, O... 2007 2026 2013 2019 2007 250 500 750
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Phase III Trial of Infusional Fluorouracil, Leucovorin, Oxaliplatin, and Irinotecan (FOLFOXIRI) Compared With Infusional Fluorouracil, Leucovorin, and Irinotecan (FOLFIRI) As First-Line Treatment for Metastatic Colorectal Cancer: The Gruppo Oncologico Nord Ovest
    2007 872 citations Alfredo Falcone, Sergio Ricci et al. Journal of Clinical Oncology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
S. Vitello Italy 7 1.0k 506 405 253 128 11 1.1k
Laura Fanchini Italy 9 938 0.9× 421 0.8× 317 0.8× 244 1.0× 104 0.8× 17 1.1k
Samanta Cupini Italy 13 834 0.8× 543 1.1× 278 0.7× 200 0.8× 79 0.6× 35 956
V. Picone Italy 4 825 0.8× 428 0.8× 314 0.8× 219 0.9× 89 0.7× 9 915
W. Evangelista Italy 4 849 0.8× 424 0.8× 303 0.7× 239 0.9× 97 0.8× 7 939
Gianfranco Porcile Italy 8 848 0.8× 421 0.8× 321 0.8× 214 0.8× 101 0.8× 18 1.0k
F. Maindrault-Gœbel France 12 1.0k 1.0× 330 0.7× 461 1.1× 405 1.6× 131 1.0× 22 1.2k
E. Pfanner Italy 12 1.3k 1.3× 674 1.3× 470 1.2× 347 1.4× 179 1.4× 28 1.5k
A. Misino Italy 11 755 0.8× 221 0.4× 368 0.9× 133 0.5× 106 0.8× 25 983
Marisa Di Seri Italy 9 631 0.6× 246 0.5× 260 0.6× 341 1.3× 96 0.8× 13 943
Clemens Gießen Germany 20 944 0.9× 288 0.6× 548 1.4× 252 1.0× 271 2.1× 46 1.1k

Countries citing papers authored by S. Vitello

Since Specialization
Citations

This map shows the geographic impact of S. Vitello's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by S. Vitello with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites S. Vitello more than expected).

Fields of papers citing papers by S. Vitello

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by S. Vitello. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by S. Vitello. The network helps show where S. Vitello may publish in the future.

Co-authorship network of co-authors of S. Vitello

This figure shows the co-authorship network connecting the top 25 collaborators of S. Vitello. A scholar is included among the top collaborators of S. Vitello based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with S. Vitello. S. Vitello is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

11 of 11 papers shown
1.
Blasi, Livio, Roberto Bordonaro, Nicolò Borsellino, et al.. (2020). Reactions and countermeasures of medical oncologists towards the incoming COVID-19 pandemic: a WhatsApp messenger-based report from the Italian College of Chief Medical Oncologists. ecancermedicalscience. 14. 1046–1046. 10 indexed citations
2.
Vitello, S., Italia Di Liegro, Alessandra Amato, et al.. (2020). Correlation between polymorphism of TYMS gene and toxicity response to treatment with 5-fluoruracil and capecitabine. European Journal of Translational Myology. 30(3). 8970–8970.
3.
Cremolini, Chiara, Fotios Loupakis, Gianluca Masi, et al.. (2016). FOLFOXIRI or FOLFOXIRI plus bevacizumab as first-line treatment of metastatic colorectal cancer: a propensity score-adjusted analysis from two randomized clinical trials. Annals of Oncology. 27(5). 843–849. 43 indexed citations
4.
5.
Re, Marzia Del, Chiara Cremolini, Fotios Loupakis, et al.. (2015). DPYD c.1905+1G>A and c.2846A>T and UGT1A1*28 allelic variants as predictors of toxicity: Pharmacogenetic translational analysis from the phase III TRIBE study in metastatic colorectal cancer.. Journal of Clinical Oncology. 33(15_suppl). 3532–3532. 1 indexed citations
6.
Cremolini, Chiara, Fotios Loupakis, Daniele Rossini, et al.. (2014). Folfoxiri with or Without Bevacizumab (Bev) As First-Line Treatment of Metastatic Colorectal Cancer (Mcrc): a Propensity Score-Based Analysis. Annals of Oncology. 25. iv175–iv175. 2 indexed citations
7.
Cremolini, Chiara, Fotios Loupakis, Sara Lonardi, et al.. (2014). Early tumor shrinkage (ETS) and deepness of response (DoR) to predict progression-free, postprogression, and overall survival: Results from the phase III TRIBE trial.. Journal of Clinical Oncology. 32(3_suppl). 521–521. 5 indexed citations
8.
Loupakis, Fotios, Chiara Cremolini, Sara Lonardi, et al.. (2014). Subgroup analyses in RAS mutant, BRAF mutant and all-wt mCRC pts treated with FOLFOXIRI plus bevacizumab (bev) or FOLFIRI plus bev in the TRIBE study.. Journal of Clinical Oncology. 32(15_suppl). 3519–3519. 13 indexed citations
9.
Falcone, Alfredo, Sergio Ricci, I. Brunetti, et al.. (2007). Phase III Trial of Infusional Fluorouracil, Leucovorin, Oxaliplatin, and Irinotecan (FOLFOXIRI) Compared With Infusional Fluorouracil, Leucovorin, and Irinotecan (FOLFIRI) As First-Line Treatment for Metastatic Colorectal Cancer: The Gruppo Oncologico Nord Ovest. Journal of Clinical Oncology. 25(13). 1670–1676. 872 indexed citations breakdown →
10.
11.
Palmeri, S., V. Leonardi, Vittorio Gebbia, et al.. (2001). Gemcitabine plus vinorelbine in stage IIIB or IV non-small cell lung cancer (NSCLC): a multicentre phase II clinical trial. Lung Cancer. 34(1). 115–123. 15 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Laura Fanchini Breakdown of academic impact, for papers by Samanta Cupini Breakdown of academic impact, for papers by V. Picone Breakdown of academic impact, for papers by W. Evangelista Breakdown of academic impact, for papers by Gianfranco Porcile Breakdown of academic impact, for papers by F. Maindrault-Gœbel Breakdown of academic impact, for papers by E. Pfanner Breakdown of academic impact, for papers by A. Misino Breakdown of academic impact, for papers by Marisa Di Seri Breakdown of academic impact, for papers by Clemens Gießen
Rankless by CCL
2026